![]() ![]() Once the partition is finished, the plates are loaded into the analyzer, where every partition undergoes an independent PCR reaction - depending on the number of plates, the process takes between an hour and a half to nearly four hours. Samples are placed in the partition plates - it uses a three-plate configuration with 20,000, 28,000, and 100,000 partitions - and then loaded in the partition engine. The platform consists of two instruments: a partition engine and an analyzer. She also said the firm plans to launch the Digital LightCycler in “select markets worldwide” by the third quarter of 2022.įend noted that the instrument would be a “great option” for applications such as treatment monitoring in oncology, environmental surveillance for infectious diseases, and donor-derived transplant rejection monitoring. Cindy Perettie, head of molecular labs at Roche, added that the sensitivity of digital PCR allows Roche to grow its portfolio for more specific testing needs and provide “more comprehensive offerings” to its customers. Roche is looking to launch the Digital LightCycler with “high-precision assays” in infectious disease and oncology, Fend said. ![]() The firm wants to make digital PCR accessible for both clinical research and laboratory developed tests, Fend said, and use the digital LightCycler to complement the company’s “strong” qPCR offerings. According to Fend, Roche is looking to bring a “competitive system” into the marketplace. Still “a very new technology” to laboratories, digital PCR allows for absolute nucleic acid quantification and superior sensitivity, Miriam Fend, Roche’s life cycle leader for PCR system, noted.īecause the technology remains novel, the digital PCR space is an open market for Roche to slot into with major players in the space including Thermo Fisher Scientific, with its QuantStudio Absolute Q Digital PCR System, Qiagen and its QIAcuity digital PCR system, Stilla Technologies with the Naica system, and Bio-Rad Laboratories and its QX digital PCR line of instruments. One key move Roche is making this year is a foray into the digital PCR market with its Digital LightCycler. With two new instrument launches planned in the US this year, Roche is continuing to broaden its molecular diagnostic offerings.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |